1/4
0/100
您的瀏覽器不支持進度條
下載所得到的文件列表
無創雙水平氣道正壓通氣聯合參麥注射液治療重度充血性心力衰竭患者的臨床研究.doc
文檔介紹:
無創雙水平氣道正壓通氣聯合參麥注射液治療重度充血性心力衰竭患者的臨床研究     【摘要】 目的研究無創雙水平氣道正壓通氣(BiPAP)聯合參麥注射液對重度充血性心力衰竭的治療效果。方法41例重度充血性心力衰竭患者隨機分為觀察組(18例)和治療組(BiPAP聯合參麥注射液)(23例),觀察兩組患者臨床療效和治療前后的血氣分析與心功能指標的改善情況。結果治療組有效率高于觀察組,差異有顯著性;治療組氧分壓(PaO2)、氧飽和度(SaO2)、心搏量、心臟指數和射血分數均明顯高于觀察組,二氧化碳分壓(PaCO2)和Boston積分均明顯低于觀察組,差異有顯著性。結論無創雙水平氣道正壓通氣聯合參麥注射液能提高重度充血性心力衰竭的治療效果,值得臨床推廣。【關鍵詞】 無創雙水平氣道正壓通氣;參麥注射液;重度充血型心力衰竭Thetherapeuticeffectofnoninvasivebi-levelpositiveairwaypressureventilationunitedwithShenmaiInjectionforseverecongestiveheartfailure   WUMeng-zhang,ZHANGYi.TheSecondXiangyaHospitalofMiddle-SouthHospital,Hunan414500,China   [Abstract] Objective Toresearchthetherapeuticeffectofnon-invasivebi-levelpositiveairway pressure(binedwithShenmaiInjectionforseverecongestiveheartfailure.Methods 41casesofseverecongestiveheartfailurewererandomlydividedintoobservationgroup(n=18)andtreatmentgroup(BiPAPunitedwithShenmaiInjection,n=23).Twogroups’therapeuticeffectandthedifferencesbetweentheresultsofcardiacfunctionandbloodgasanalysisbeforeandafterthetreatmentwereobserved.Results Thetherapeuticeffectofthetreatmentgroupwasmuchgreaterthanthatofobservationgroup,andthedifferencewassignificant.Partialpressureofoxygen(PaO2),oxygensaturation(SaO2),strokevolume,ejectionfractionandcardiacindexinthetreatmentgroupweresignificantlyhigherthanthoseintheobservationgroup.Partialpressureofcarbondioxide(PaCO2)andBostonpointsintreatmentgroupweresignificantlylowerthant 內容來自淘豆網www.eawpme.live轉載請標明出處.
北京单场开奖